[1,4] MECHANISM OF ACTION Semaglutide is a GLP-1 receptor agonist [Figure 1] that enhances insulin secretion while reducing glucagon release
When intake is low, people may also unintentionally reduce foods that carry key micronutrients (like B vitamins and iron), particularly if they're avoiding meat, dairy, or legumes due to nausea or intolerance
Key Takeaways Wegovy Pill (oral semaglutide, 25 mg, Novo Nordisk) was FDA-approved for weight loss on December 22nd, 2025 with the medication expected to be available to patients in early January 2026
This collaborative approach helps ensure appropriate individualization of treatment while minimizing the risk of adverse effects
The Oral Wegovy Pill Is Here: What Patients in Murphy and Plano Need to Know The oral Wegovy pill became the first FDA-approved GLP-1 medication in tablet form for weight loss when it cleared regulatory review in December 2025 and patients across the Dallas-Fort Worth area have been asking about it ever since